Navigation Links
SpectraCell Contracts With Beech Street Corporation

HOUSTON, Sept. 10 /PRNewswire/ -- SpectraCell Laboratories announced today it has signed a provider agreement with Beech Street Corporation, one of the nation's largest preferred provider organizations (PPO), for healthcare management services. Beech Street will assist SpectraCell with the ever-increasing administrative needs that accompany healthcare reimbursement coverage for an expanding laboratory.

Beech Street addresses the various coverage obstacles in today's healthcare environment, and acts as a liaison between SpectraCell and other healthcare stakeholders such as HMO's and medical insurance companies. The Beech Street payor list contains over 1000 companies, including many insurance giants and covers 16 million eligible individuals nationally.

"Health care costs have risen astronomically in recent years, which has created a sort of battle between consumers, insurance carries and providers, even though their underlying goal is really the same - health and wellness." comments Rusty Preece, VP and CFO of SpectraCell. "The decades of experience that Beech Street has will help us bridge the gap in the often complicated world of managed care and healthcare policy."

The contract with Beech Street covers one year of service and will be reviewed annually. Due to increasing numbers of doctors that understand the value of micronutrient testing, advanced lipid testing, and laboratory services aimed at prevention and earlier diagnosis, SpectraCell Laboratories continues to grow. The company's number of employees has more than doubled since 2005 and SpectraCell now serves over 3,500 physician clients in 42 states.

About SpectraCell Laboratories - SpectraCell is a CLIA accredited laboratory that services healthcare providers nationwide by providing advanced diagnostics with micronutrient testing and the Lipoprotein Particle Profile(TM) (LPP).

SpectraCell's micronutrient testing is an innovative assessment of a patient's nutritional status. Unlike traditional serum, hair and urine tests, SpectraCell's testing measures how an individual's white blood cells function in specific nutritional environments. Over 31 vitamins, minerals, amino acids and antioxidants are evaluated. As a result, individual differences in metabolism, age, genetics, health, prescription drug usage, absorption rate and other factors are taken into consideration.

SpectraCell's Lipoprotein Particle Profile(TM) is the most advanced lipoprotein test available. Unlike traditional cholesterol tests, SpectraCell's LPP(TM) directly measures both the size and number of several classes of lipoprotein particles, providing an accurate assessment of cardiovascular risk.

SOURCE SpectraCell Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SpectraCell Laboratories Now Measures Vitamin C
2. Mirus Bio Awarded Grants & Contracts of Over $5 Million
3. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
4. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
5. HealthEast Care System Selects Concuitys ClearContracts to Increase Contract Analysis and Negotiation Capabilities and Improve Revenue Cycle Management
6. Campbell Alliance Trade and Distribution Practice to Speak at CBIs Commercial Contracts and Chargeback Management Conference
7. Sales Contracts Worth $2.3 Million Signed Since 1 July 2008
8. BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
9. Therapure Biopharma Inc. opens for business with first client contracts
10. Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers
11. Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts
Post Your Comments:
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology:
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... 2016 , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
Breaking Biology News(10 mins):